23 Measurements + 4 Composite Scores.
20 Minutes. $189.

Walk-in point-of-care screening — cardiovascular, metabolic, hormonal, and more. Same-day results.

Book Your Assessment
FDA-Cleared Devices Medical-Grade EKG Results in 20 min

What We Measure

23 clinical measurements and 4 composite scores using medical-grade devices.

Cardiovascular

9 measurements
  • Blood pressure (systolic & diastolic)
  • 6-lead EKG: heart rhythm, rate, atrial fibrillation screening
  • Single-lead ECG confirmation
  • Vascular age estimate
  • Nitric oxide level (endothelial function)
  • Total cholesterol
  • Triglycerides
  • HDL cholesterol
  • LDL cholesterol

Includes all biomarkers required for Framingham Risk Score calculation.

Metabolic & Body Composition

5 measurements
  • Fasting blood glucose
  • Body fat % (segmental)
  • Skeletal muscle mass (segmental)
  • Body water %
  • Weight

Neurological / Autonomic

1 measurement
  • Electrodermal activity (peripheral nerve health)

Endocrine & Nutritional

1 measurement
  • Vitamin D level

Physical & Respiratory

7 measurements

FEV1 and grip strength are among the strongest physical predictors of all-cause mortality.

Composite Scores

4 derived values

Calculated from your direct measurements — no additional testing required.

All testing uses FDA-cleared, medical-grade point-of-care devices. Results are reviewed and explained during your visit.

Longevity Biomarkers

Many of the markers we measure have robust, well-documented associations with all-cause mortality. Data sourced from MortalityPredictors.org, a curated database of 1,576 published biomarker–mortality associations.

Blood Pressure
Systolic blood pressure — one of the most-studied mortality predictors, with data spanning decades of research.
Cardiovascular
↓ Mortality risk↑ Mortality risk
Per 10 mmHg increase in systolic BP
Satish 2001
1.10 (1.07–1.13)
Ben-Dov 2011
1.09 (1.04–1.14)
Horibe 2005
1.04 (1.01–1.07)
Puddu 2014
1.07 (1.03–1.10)
Lan 2007
1.10 (1.04–1.17)
Average
1.08
Fasting Glucose
The #1 most-published blood biomarker in the database. Elevated levels predict shorter lifespan even in pre-diabetic ranges.
Metabolic
↓ Mortality risk↑ Mortality risk
Per 1 mmol/L increase in fasting glucose
Barr 2009
1.10 (1.00–1.20)
von Gunten 2013
1.08 (1.04–1.13)
Horibe 2005
1.06 (1.04–1.07)
Puddu 2014
1.11 (1.07–1.17)
Lan 2007
1.10 (1.05–1.17)
Average
1.09
Total Cholesterol
Decades of evidence linking lifetime lipid exposure to cardiovascular and all-cause mortality.
Cardiovascular
↓ Mortality risk↑ Mortality risk
Per 1 mmol/L increase in total cholesterol
Goldbourt 1990
1.07 (1.03–1.12)
Neas 1998
1.08 (1.00–1.16)
Domanski 2001
1.21 (1.00–1.45)
Nomikos 2015
1.26 (1.00–1.65)
Average
1.15
HDL Cholesterol
Higher levels consistently associated with lower cardiovascular and all-cause mortality across populations.
Cardiovascular
↓ Mortality risk↑ Mortality risk
Per 1 SD increase in HDL cholesterol
Sritara 2007
0.68 (0.54–0.87)
Goldbourt 1990
0.88 (0.82–0.94)
Average
0.77
Vitamin D
25-hydroxyvitamin D is a top-10 biomarker. Deficiency associated with increased all-cause mortality.
Endocrine
↓ Mortality risk↑ Mortality risk
Per 25 nmol/L (10 ng/mL) increase in serum 25(OH)D
Saliba 2014
0.67 (0.61–0.73)
Afzal 2014
0.80 (0.76–0.85)
Khaw 2014
0.90 (0.85–0.95)
Skaaby 2013
0.88 (0.81–0.98)
Kestenbaum 2011
0.92 (0.85–0.98)
Average
0.83
Nitric Oxide (Endothelial Function)
Elevated serum NO metabolites independently predict all-cause mortality across multiple prospective cohorts. Our salivary test strip is a screening proxy for NO bioavailability — not a direct measure of serum NOx.
Cardiovascular
↓ Mortality risk↑ Mortality risk
Elevated vs. normal serum NO metabolites (NOx)
Maas 2017
1.21 (1.04–1.40)
Bahadoran 2019
1.52 (1.05–2.21)
Gumanova 2019
1.40 (1.06–1.80)
Average
1.38
BMI
U-shaped relationship with mortality. Lowest risk at BMI 20–25; obesity significantly increases risk.
Body Composition
↓ Mortality risk↑ Mortality risk
Per 5 kg/m² increase in BMI (above normal range)
Chen 2012
1.27 (1.15–1.40)
Mason 2008
1.15 (1.02–1.29)
Taylor 2010 (M)
1.10 (1.03–1.17)
Taylor 2010 (F)
1.11 (1.01–1.22)
Average
1.16
Skeletal Muscle Mass
Low muscle mass consistently predicts higher all-cause mortality across meta-analyses. One of the strongest longevity predictors in aging research.
Body Composition
↓ Mortality risk↑ Mortality risk
Low vs. normal skeletal muscle mass index
Wang 2023
1.57 (1.25–1.96)
Liu 2017
1.60 (1.24–2.06)
Szulc 2010
1.33 (1.06–1.66)
Srikanthan 2014
1.25 (1.03–1.52)
Average
1.44
Body Fat %
Superior to BMI for mortality prediction. Visceral fat drives inflammation, insulin resistance, and cardiovascular disease.
Body Composition
FEV1 (Spirometry)
One of the strongest physical predictors of all-cause mortality, even in non-smokers.
Respiratory
↓ Mortality risk↑ Mortality risk
Per 1 liter decrease in FEV1
Becker 2013
1.85 (1.14–3.03)
Neas 1998
1.56 (1.35–1.79)
Hebert 2010 (F)
1.19 (1.15–1.22)
Hebert 2010 (M)
1.16 (1.15–1.19)
Average
1.41
Grip Strength
A top-tier mortality predictor reflecting whole-body muscular reserve and frailty risk.
Physical
↓ Mortality risk↑ Mortality risk
Per 5 kg decrease in grip strength
Leong 2015
1.16 (1.13–1.20)
Bates 2012
1.18 (1.10–1.25)
Gale 2007
1.11 (1.03–1.20)
Average
1.15
Resting Heart Rate
Higher resting rate reflects reduced cardiovascular fitness and autonomic dysfunction.
Cardiovascular
↓ Mortality risk↑ Mortality risk
Per 10 bpm increase in resting heart rate
Mensink 1997 (M)
1.30 (1.18–1.55)
Mensink 1997 (F)
1.18 (1.05–1.34)
Aladin 2014 (M)
1.19 (1.14–1.24)
Aladin 2014 (F)
1.12 (1.06–1.18)
Jensen 2013
1.32 (1.18–1.48)
Average
1.22
Waist-to-Hip Ratio
Superior to BMI for predicting visceral adiposity and cardiovascular mortality.
Body Composition
↓ Mortality risk↑ Mortality risk
Per 1 SD increase in waist-to-hip ratio
Welborn 2007 (M)
1.25 (1.11–1.42)
Welborn 2007 (F)
1.24 (1.07–1.43)
Mason 2008
1.18 (1.04–1.34)
Taylor 2010 (F)
1.15 (1.05–1.26)
Taylor 2010 (M)
1.08 (1.01–1.16)
Average
1.18
Waist-to-Height Ratio
A ratio above 0.5 consistently predicts increased all-cause mortality. Simpler and more universal than BMI.
Body Composition
↓ Mortality risk↑ Mortality risk
Per 1 SD increase in waist-to-height ratio
Taylor 2010 (F, BMI≥22.5)
1.26 (1.14–1.38)
Schneider 2012
1.19 (1.05–1.36)
Taylor 2010 (M, BMI≥22.5)
1.12 (1.04–1.20)
Taylor 2010 (F, all)
1.10 (1.01–1.20)
Average
1.17
Pulse Oximetry (SpO2)
Resting SpO2 below 92% is associated with roughly doubled mortality risk vs. ≥96%, signaling cardiopulmonary compromise.
Respiratory
↓ Mortality risk↑ Mortality risk
SpO2 ≤92% vs. ≥96%
Vold 2015
1.99 (1.33–2.96)
Average
1.99
Waist Circumference
Large waist circumference reflects visceral fat accumulation and predicts all-cause mortality independent of BMI.
Body Composition
↓ Mortality risk↑ Mortality risk
Per 1 SD increase in waist circumference
Taylor 2010 (F)
1.25 (1.14–1.37)
Staiano 2012
1.19 (1.11–1.27)
Janssen 2005
1.19 (1.02–1.40)
Mason 2008
1.17 (1.04–1.33)
Taylor 2010 (M)
1.10 (1.02–1.18)
Average
1.18

How It Works

Three simple steps to a comprehensive health snapshot.

Book Online

Pick a 20-minute slot that works for you

Skip Breakfast

8-hour fast recommended for glucose and lipid accuracy

Get Results Same Day

We walk you through every measurement before you leave

Pricing

Simple, transparent, no surprises.

$189
All-Inclusive

Every measurement listed above. No hidden fees. No insurance needed. No referral required.

Follow-up reassessment (repeat all biomarkers): $149

Add-On Testing

PSA Screening

Prostate-specific antigen test — recommended for men over 40 as part of routine cancer screening.

$49

Lactate Threshold Test

30-minute incremental exercise protocol to pinpoint your aerobic and anaerobic thresholds — essential data for endurance training and metabolic optimization. (50 minutes total with comprehensive assessment.)

Book Assessment + Lactate Threshold
$119

Who This Is For

If any of these sound like you, this workup was designed for you.

Book Your Assessment

Choose a time that works for you. We'll handle the rest.

Having trouble booking? WhatsApp us